These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Agonist and inverse agonist efficacy at human recombinant serotonin 5-HT1A receptors as a function of receptor:G-protein stoichiometry. Newman-Tancredi A; Conte C; Chaput C; Verrièle L; Millan MJ Neuropharmacology; 1997; 36(4-5):451-9. PubMed ID: 9225269 [TBL] [Abstract][Full Text] [Related]
13. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors. Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513 [TBL] [Abstract][Full Text] [Related]
14. Characterization of [3H]5-hydroxytryptamine and [3H]spiperone binding sites in clathrin-coated vesicles from bovine brain. Moroi K; Ozaki N; Kadota T; Kadota K Brain Res; 1998 Jun; 794(2):291-8. PubMed ID: 9622654 [TBL] [Abstract][Full Text] [Related]
15. [3H]spiroxatrine: a 5-HT1A radioligand with agonist binding properties. Herrick-Davis K; Titeler M J Neurochem; 1988 Feb; 50(2):528-33. PubMed ID: 2961850 [TBL] [Abstract][Full Text] [Related]
16. [Multiple [3H]8-hydroxy-2-(di-n-propylamino)-tetralin binding sites in rat brain: modulation by GTP and cations]. Yokota N; Yamawaki S; Hayakawa H; Yoshida R; Sarai K Yakubutsu Seishin Kodo; 1989 Jun; 9(2):197-206. PubMed ID: 2530729 [TBL] [Abstract][Full Text] [Related]
17. Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist. Jerning E; Svantesson GT; Mohell N Eur J Pharmacol; 1998 Nov; 360(2-3):219-25. PubMed ID: 9851589 [TBL] [Abstract][Full Text] [Related]
18. Detection of the 5-HT1A receptor and 5-HT1A receptor mRNA in the rat bowel and pancreas: comparison with 5-HT1P receptors. Kirchgessner AL; Liu MT; Howard MJ; Gershon MD J Comp Neurol; 1993 Jan; 327(2):233-50. PubMed ID: 8425944 [TBL] [Abstract][Full Text] [Related]
19. Modulation of 5-hydroxytryptamine1A receptor density by nonhydrolyzable GTP analogues. Harrington MA; Peroutka SJ J Neurochem; 1990 Jan; 54(1):294-9. PubMed ID: 2136705 [TBL] [Abstract][Full Text] [Related]
20. Potency of 5-hydroxytryptamine1a agonists to inhibit adenylyl cyclase activity is a function of affinity for the "low-affinity" state of [3H]8-hydroxy-N,N-dipropylaminotetralin ([3H]8-OH-DPAT) binding. Chamberlain J; Offord SJ; Wolfe BB; Tyau LS; Wang HL; Frazer A J Pharmacol Exp Ther; 1993 Aug; 266(2):618-25. PubMed ID: 8355195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]